Inhibition of allergen-induced wheal and flare reactions by levocetirizine and desloratadine

British Journal of Clinical Pharmacology

Volumn 65, Issue 2, 2008, Pages 172-179

  Frossard, Nelly ^a   Strolin Benedetti, Margherita ^b   Purohit, Ashok ^c   Pauli, Gabrielle ^c  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UCB   (Belgium)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Allergen; Antihistamine; Desloratadine; Levocetirizine; Pharmacokinetics; Skin; Wheal and flare reactions

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; DESLORATADINE; LEVOCETIRIZINE; PLACEBO;

ADULT; ANALYSIS OF VARIANCE; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG INHIBITION; DRUG POTENCY; DRUG SAFETY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URTICARIA;

ADOLESCENT; ADULT; ALLERGENS; CETIRIZINE; CHOLINERGIC ANTAGONISTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; LORATADINE; MALE; MIDDLE AGED; PIPERAZINES; PROSPECTIVE STUDIES; URTICARIA;

EID: 38649099362     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2007.03009.x     Document Type: Article

References (22)

1. Holgate ST, Lack G. Improving the management of atopic disease. Arch Dis Child 2005 90 : 826 31.
2. 1-antihistamines: From concept to reality. Clin Exp Allergy Rev 2003 3 : 87 9.
3. Purohit A, Melac M, Pauli G, Frossard N. Twenty-four-hour activity and consistency of activity of levocetirizine and desloratadine in the skin. Br J Clin Pharmacol 2003 56 : 388 94.
4. Denham KJ, Boutsiouki P, Clough GF, Church MK. Comparison of the effects of desloratadine and levocetirizine on histamine-induced wheal, flare and itch in human skin. Inflamm Res 2003 52 : 424 7.
5. 1 antagonists: receptor affinity versus selectivity. Inflamm Res Supplement 2003 1 : S49 50.
6. Anthes JC, Gilchrest H, Richard C, Eckel S, Hesk D, West RE Jr., Williams SM, Greenfeder S, Billah M, Kreutner W, Egan RE. Biochemical characterization of desloratadine, a potent antagonist of the human histamine H (1) receptor. Eur J Pharmacol 2002 449 : 229 37.
7. 1 antihistamines: clinical relevance. Am J Med 2002 16 : 113(Suppl : 38S 46S.
8. Bloebaum RM, Grant JA. Levocetirizine: the allergist's arsenal grows larger. Expert Opin Pharmacother 2004 5 : 1581 8.
9. Norman P, Dihlmann A, Rabasseda X. Desloratadine: a preclinical and clinical overview. Drugs Today (Barc) 2001 37 : 215 27.
10. 1-receptor antagonist, in humans. Fundam Clin Pharmacol 2002 16 : 471 8.
11. Molimard M, Diquet B, Benedetti MS. Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans. Fundam Clin Pharmacol 2004 18 : 399 411.
12. 1-antihistamines. Inflamm Res 2005 54 : 367 9.
13. Frossard N, Vital-Durand D, Mounedji N, Valleteau A. Duration of the antihistaminic effect after discontinuation of ebastine. Allergy 2001 56 : 553 7.
14. Popov TA, Dumitrascu D, Bachvarova A, Bocsan C, Dimitrov V, Church MK. A comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivo. Inflamm Res 2006 55 : 241 4.
15. Pasquali M, Balardini I, Rogkakou A, Riccio AM, Gamalero C, Descalzi D, Folli C, Passalacqua G, Canonica GW. Levocetirizine in persisten allergic rhinitis and asthma. Effects on symptoms, quality of life and inflammatory parameters. Clin Exp Allergy 2006 36 : 1161 7.
16. Walsh GM. Levocetirizine: an update. Curr Med Chem 2006 13 : 2711 5.
17. Hair PI, Scott LJ. Levocetirizine. A review of its use in the management of allergic rhinitis and skin allergies. Drugs 2006 66 : 973 96.
18. Ciprandi G, Cirillo I, Vizzaccaro A, Civardi E, Barberi S, Allen M, Marseglia GL. Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study. Int Immunopharmacol 2005 5 : 1800 8.
19. Mullol J, Roca-Ferrer J, Alobid I, Pujols L, Valero A, Xaubet A, Bernal-Sprekelsen M, Picado C. Effect of desloratadine on epithelial cell granulocyte-macrophage colony-stimulating factor secretion and eosinophil survival. Clin Exp Allergy 2006 36 : 52 8.
20. Reinartz SM, Overbeek SE, Kleinjan A, Drunen CM, Braunstahl GJ, Hoogsteden HC, Fokkens WJ. Desloratadine reduces systemic allergic inflammation following nasal provocation in allergic rhinitis and asthma patients. Allergy 2005 60 : 1301 7.
21. Persi L, Demoly P, Harris AG, Tisserand B, Michel FB, Bousquet J. Comparison between nasal provocation tests and skin tests in patients treated with loratadine and cetirizine. J Allergy Clin Immunol 1999 103 : 591 4.
22. MacGlashan D Jr. Histamine: a mediator of inflammation. J Allergy Clin Immunol 2003 112 (Suppl. 4 S53 9.